• small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

2017 News Releases

Webcast ImageWebcast
MIMEDX GROUP INC at the 35th Annual JP Morgan Healthcare Conference (Replay)
Jan 12, 2017 at 9:00 a.m. PT
MIMEDX GROUP INC at the 35th Annual JP Morgan Healthcare Conference
Thursday, January 12, 2017 9:00 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
Jan 09, 2017MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance
$246.8 Million Full Year 2016 Revenue is a 32% Increase Over 2015 and $71.6 Million Q4 2016 Revenue is a 38% Increase Over Q4 2015 MARIETTA, Ga., Jan. 9, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, today announced ... 
Printer Friendly Version
Jan 03, 2017MiMedx to Present at 35th Annual J.P. Morgan Healthcare Conference
MARIETTA, Ga., Jan. 3, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today the schedule for its presentation at the 35th Annual J.P. Morgan Healthcare Conference.  Parker H. "Pete" Petit, Chairman and CEO, Wil... 
Printer Friendly Version

Products

CONTACT US

888.543.1917